|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.93/--
|
企業價值
352.36M
|
資產負債 |
每股賬面淨值
-7.87
|
現金流量 |
現金流量率
--
|
損益表 |
收益
33.49M
|
每股收益
--
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/11/10 17:32 EST
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program ofthe company includes Artiva-Funded Trials and Collaborator-Funded Trials. |